Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 3Gynecologic 2Genitourinary 2Breast 2Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 15Sezary Syndrome 13Mycosis Fungoides 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Lymphocytic, Chronic, B-Cell 11Burkitt Lymphoma 11Leukemia, Myeloid, Acute 10Hodgkin Disease 10Myeloproliferative Disorders 9Multiple Myeloma 9Melanoma 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Hairy Cell 9Congenital Abnormalities 9Blast Crisis 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Myeloid, Accelerated Phase 8Primary Myelofibrosis 7Pdgfra-Associated Chronic Eosinophilic Leukemia 7Lymphoma 7Leukemia, Neutrophilic, Chronic 7Lymphoma, Extranodal NK-T-Cell 5Waldenstrom Macroglobulinemia 4

Interventions

Docetaxel 3trastuzumab deruxtecan 1tanespimycin 1sargramostim 1pertuzumab 1pembrolizumab 1larotrectinib 1entrectinib 1entinostat 1alectinib 1aldesleukin 1Vorinostat 1Trastuzumab 1Thalidomide 1Ritonavir 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Microarray Analysis 1Indinavir 1Immunotherapy 1Immunohistochemistry 1Immunoenzyme Techniques 1Gene Expression Profiling 1Gemcitabine 1Flow Cytometry 1Filgrastim 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Flow Cytometry × Dermatologic × Clear all
NCT00904514 2018-10-05

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

National Institutes of Health Clinical Center (CC)

Terminated
241 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Brenner Tumor, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sezary Syndrome, Stomach Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡